Reports On Company: JB Chem
| JB Chemicals is the preferred pick in the Pharma sector: Nirmal Bang | |
| Company: | JB Chem |
| Brokerage: | Nirmal Bang |
| Date of report: | December 18, 2022 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 15.2% |
| Summary: | JB Chem has 7 formulations facilities and 1 API facility with most of the units approved by all major compliance agencies, including units TI10 (OSD), T20 (OSD) and D9 (API), which are USFDA compliant as well. |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | |